Sphere Fluidics to Present on ESI-Mine at COEBP 4th Annual Symposium
Dr Frank F. Craig (CEO) will be speaking on application of Sphere Fluidics’ ESI-Mine platform for Synthetic Biology at the Centre for Excellence in Biopharmaceuticals symposium on 1st July at the University of Manchester (UK). “ESI-Mine is our new platform that enables high-throughput, miniaturised screening using mass spectrometry. We can do around 200,000 samples day (c.f. 1-10,000 by normal techniques). This platform has immense potential to transform synthetic biology and metabolomic studies”. Conference information can be found here.